Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PBYI Puma Biotechnology

Post-Mkt 02-13 19:37:40 EST

6.82

+0.02

+0.29%

盘后6.80

-0.02-0.29%

17:25 EST

High6.99	Low6.70	Vol301.43K
Open6.79	D1 Closing6.80	Amplitude4.26%
Mkt Cap343.67M	Tradable Cap263.00M	Total Shares50.39M
T/O2.06M	T/O Rate0.78%	Tradable Shares38.56M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"PBYI","market":"US","secType":"STK","nameCN":"Puma Biotechnology","latestPrice":6.82,"timestamp":1771016400000,"preClose":6.8,"halted":0,"volume":301428,"hourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":6.82,"latestTime":"17:25 EST","volume":3324,"amount":22652.4294372,"timestamp":1771021515426,"change":-0.02,"changeRate":-0.002933,"amplitude":0.036686},"delay":0,"changeRate":0.0029411764705883033,"floatShares":38562636,"shares":50391107,"eps":0.744238,"marketStatus":"Post-Mkt","change":0.02,"latestTime":"02-13 19:37:40 EST","open":6.79,"high":6.99,"low":6.7,"amount":2064727.7238168,"amplitude":0.042647,"askPrice":7.51,"askSize":100,"bidPrice":6.28,"bidSize":100,"shortable":3,"etf":0,"ttmEps":0.744238,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1771030800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":1332302400000,"exchange":"NASDAQ","adjPreClose":6.8,"preHourTrading":{"tag":"盘前","latestPrice":6.8,"preClose":6.8,"latestTime":"09:29 EST","volume":97,"amount":659.6,"timestamp":1770992999089,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":6.8,"preClose":6.82,"latestTime":"17:25 EST","volume":3324,"amount":22652.4294372,"timestamp":1771021515426,"change":-0.02,"changeRate":-0.002933,"amplitude":0.036686},"volumeRatio":0.82685,"impliedVol":1.1045,"impliedVolPercentile":0.3825},"requestUrl":"/m/hq/s/PBYI","defaultTab":"news","newsList":[{"id":"2611547970","title":"Puma Biotechnology Inc. to Host Conference Call on Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2611547970","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611547970?lang=en_us&edition=fundamental","pubTime":"2026-02-13 05:10","pubTimestamp":1770930626,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. will release its fourth quarter and full year 2025 financial results on Thursday, February 26, 2026. The company will host a conference call to discuss the results at 1:30 p.m. PT/4:30 p.m. ET. The call and presentation slides will be available via a live webcast in the Investors section of the Puma Biotechnology website. A replay will be archived on the website for 90 days.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on February 12, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260212:nNDL95zHZj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2609311417","title":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule","url":"https://stock-news.laohu8.com/highlight/detail?id=2609311417","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609311417?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:58","pubTimestamp":1770245936,"startTime":"0","endTime":"0","summary":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing RuleFeb 4 (Reuters) - Puma Biotechnology Inc PBYI.O:PUMA BIOTECHNOLOGY REPORTS INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA6MCKDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2609333319","title":"Puma Biotechnology Grants Inducement Stock Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2609333319","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609333319?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:05","pubTimestamp":1770242711,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. announced the grant of inducement restricted stock unit awards covering 14,750 shares of common stock to two new non-executive employees. These awards vest over a three-year period, with one-third vesting on the first anniversary of the vesting commencement date, February 1, 2026, and one-sixth vesting on each six-month anniversary thereafter, subject to continued service.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on February 04, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nNDL50FdVS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2609319887","title":"Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609319887","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609319887?lang=en_us&edition=fundamental","pubTime":"2026-02-05 06:05","pubTimestamp":1770242700,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260204:nTUA6MCKDY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2608879115","title":"Rigel Pharmaceuticals beruft Michael P. Miller in den Vorstand","url":"https://stock-news.laohu8.com/highlight/detail?id=2608879115","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608879115?lang=en_us&edition=fundamental","pubTime":"2026-02-03 21:05","pubTimestamp":1770123921,"startTime":"0","endTime":"0","summary":"Rigel Pharmaceuticals Inc. hat die Ernennung von Michael P. Miller in den Vorstand bekannt gegeben. Miller verfügt über mehr als vierzig Jahre Erfahrung in kommerziellen und leitenden Positionen in der Biotechnologie- und Pharmaindustrie und ist derzeit auch in den Vorstnden von Puma Biotechnology und BioXcel Therapeutics ttig.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Rigel Pharmaceuticals Inc. published the original content used to generate this news brief via PR Newswire  on February 03, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nNDL8rsG3g:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI","BTAI","RIGL"],"gpt_icon":0},{"id":"2602231212","title":"Puma Biotechnology CFO Maximo Nougues Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2602231212","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602231212?lang=en_us&edition=fundamental","pubTime":"2026-01-09 09:15","pubTimestamp":1767921328,"startTime":"0","endTime":"0","summary":"Maximo F. Nougues, Chief Financial Officer of Puma Biotechnology Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on January 08, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260109:nNDL8c00Jw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Puma Biotechnology CFO Maximo Nougues Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2601384435","title":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2601384435","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601384435?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:28","pubTimestamp":1767824902,"startTime":"0","endTime":"0","summary":"BRIEF-Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)Jan 8 (Reuters) - Puma Biotechnology Inc PBYI.O:PUMA BIOTECHNOLOGY REPORTS INDUCEMENT AWARDS UNDER NASDAQ LISTING","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nTUAKCDT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","PBYI"],"gpt_icon":0},{"id":"2601563384","title":"Puma Biotechnology Grants Inducement Stock Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2601563384","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601563384?lang=en_us&edition=fundamental","pubTime":"2026-01-08 06:15","pubTimestamp":1767824114,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. announced that its Compensation Committee approved inducement restricted stock unit awards covering 10,500 shares of Puma common stock to three new non-executive employees. The awards will vest over a three-year period, with one-third vesting on January 1, 2026, and the remaining shares vesting in equal portions every six months thereafter, contingent on continued employment.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on January 07, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260107:nNDL96lP7Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2593273472","title":"US Market's Undiscovered Gems to Explore This December 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2593273472","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593273472?lang=en_us&edition=fundamental","pubTime":"2025-12-24 19:03","pubTimestamp":1766574188,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues to reach new heights, with the S&P 500 closing at a record high after a series of positive economic indicators, investors are keenly observing the landscape for promising opportunities. In this vibrant market environment, identifying undiscovered gems among small-cap stocks can offer unique growth potential, especially as these companies often thrive in periods of robust economic expansion and increased consumer spending.","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pbyi/puma-biotechnology/news/us-markets-undiscovered-gems-to-explore-this-december-2025","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-pbyi/puma-biotechnology/news/us-markets-undiscovered-gems-to-explore-this-december-2025","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SD","ITRN","BK4139","BK4020","PBYI","BK4213"],"gpt_icon":0},{"id":"2593455668","title":"Puma Biotechnology Added to Nasdaq Biotechnology Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2593455668","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593455668?lang=en_us&edition=fundamental","pubTime":"2025-12-23 06:29","pubTimestamp":1766442580,"startTime":"0","endTime":"0","summary":"Puma Biotechnology (PBYI) said late Monday it has been added to the Nasdaq Biotechnology Index, effective at the close of trading on Dec. 19.Shares were over 1% higher in extended trading.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","NQmain","PBYI"],"gpt_icon":0},{"id":"2593586124","title":"Puma Biotechnology Joins Nasdaq Biotechnology Index","url":"https://stock-news.laohu8.com/highlight/detail?id=2593586124","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593586124?lang=en_us&edition=fundamental","pubTime":"2025-12-23 05:10","pubTimestamp":1766437812,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. will be added to the Nasdaq Biotechnology Index  effective at the close of trading on December 19, 2025. The company’s inclusion recognizes its continued commercial execution, profitability, and clinical progress.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Puma Biotechnology Inc. published the original content used to generate this news brief via Business Wire  on December 22, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251222:nNDLcdn1XX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2588061649","title":"Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2588061649","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588061649?lang=en_us&edition=fundamental","pubTime":"2025-12-03 06:15","pubTimestamp":1764713700,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251202:nTUA54H07G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2586723261","title":"GoodRx Holdings And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2586723261","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586723261?lang=en_us&edition=fundamental","pubTime":"2025-11-27 01:05","pubTimestamp":1764176721,"startTime":"0","endTime":"0","summary":"As the U.S. stock market continues its upward trajectory, with major indexes marking their biggest weekly rise since June, investors are increasingly exploring diverse opportunities to capitalize on this momentum. Penny stocks, a term that may seem outdated yet remains significant, represent smaller or newer companies that can potentially offer substantial returns when they are built on solid financial foundations. In this article, we will explore three penny stocks that exhibit strong...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice1-main-header/1585186828574"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/goodrx-holdings-and-2-other-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-gdrx/goodrx-holdings/news/goodrx-holdings-and-2-other-promising-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4023","BK4113","BK4077","BK4139","CRCT","BABB","BK4551","BK4180","PBYI","BK4021","BK4173","BK4209","LU1046422090.SGD","BK4579","TBLA","GDRX","DDL","LCUT","BK4167","LX","MAPS","PSHG","BK4134","LU0049112450.USD","BK4166","WDH","BK4531","BK4539","RSKD","CINT","LU1235295612.USD","BK4191","BK4509"],"gpt_icon":0},{"id":"2586405061","title":"Alpha Teknova Among 3 Penny Stocks Worth Noting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586405061","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586405061?lang=en_us&edition=fundamental","pubTime":"2025-11-26 01:04","pubTimestamp":1764090294,"startTime":"0","endTime":"0","summary":"As the U.S. stock market experiences a mixed performance with major indices like the Dow Jones and S&P 500 showing gains, while tech-heavy sectors face challenges, investors are exploring diverse opportunities. Penny stocks, though an older term in investing, continue to represent a segment of smaller or less-established companies that can offer significant value. By focusing on those with strong financial health and potential for growth, investors can discover promising opportunities among...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8032000-choice1-main-header/1585186551780"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-mq/marqeta/news/alpha-teknova-among-3-penny-stocks-worth-noting","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/diversified-financials/nasdaq-mq/marqeta/news/alpha-teknova-among-3-penny-stocks-worth-noting","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4180","BABB","BK4113","LX","NEPH","BK4121","BK4096","LU0049112450.USD","CINT","BK4134","LU1235295612.USD","BK4561","WDH","BK4106","BK4173","MQ","FINV","BK4191","BK4209","BK4531","BK4535","PBYI","DDL","PSHG","BK4161","LCUT","BK4227","BK4539","BK4551","BK4149","BK4166","TKNO","BK4139","HYLN","BK4579","BK4021","LU1046422090.SGD","BK4509"],"gpt_icon":0},{"id":"2586427205","title":"Clover Health Investments And 2 Other Penny Stocks With Promising Financials","url":"https://stock-news.laohu8.com/highlight/detail?id=2586427205","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586427205?lang=en_us&edition=fundamental","pubTime":"2025-11-25 19:05","pubTimestamp":1764068707,"startTime":"0","endTime":"0","summary":"As the U.S. markets kick off a holiday-shortened trading week with significant gains, optimism is building around the potential for a Federal Reserve interest rate cut in December. In such an environment, investors often look to diversify their portfolios by exploring various investment opportunities, including penny stocks. Although the term 'penny stock' might seem outdated, it still represents smaller or emerging companies that can offer substantial value when backed by strong financials...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/7211000-choice2-main-header/1585187169399","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/7211000-choice2-main-header/1585187169399"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/insurance/nyse-wdh/waterdrop/news/clover-health-investments-and-2-other-penny-stocks-with-prom","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/insurance/nyse-wdh/waterdrop/news/clover-health-investments-and-2-other-penny-stocks-with-prom","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SMRT","BK4161","PSHG","NEPH","BK4547","WDH","BK4021","LCUT","BK4509","BK4113","BK4157","CINT","BK4139","BK4180","BK4579","BABB","LX","BK4551","FINV","LU1046422090.SGD","BK4209","PBYI","BK4134","BK4173","BK4166","BK4539","LU0049112450.USD","BK4531","LU1235295612.USD","CLOV","DDL","BK4191","BK4154"],"gpt_icon":0},{"id":"2585666224","title":"November 2025's Top Penny Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2585666224","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585666224?lang=en_us&edition=fundamental","pubTime":"2025-11-24 19:05","pubTimestamp":1763982308,"startTime":"0","endTime":"0","summary":"As November 2025 unfolds, the U.S. stock market has experienced a turbulent week, with major indices closing lower despite a strong finish on Friday and growing optimism for an interest rate cut by the Federal Reserve. Amidst these fluctuations, investors are exploring diverse opportunities to navigate the shifting landscape. Penny stocks, often associated with smaller or emerging companies, continue to draw attention for their potential growth prospects at accessible price points. While the...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/3072000-choice1-main-header/1585186775716","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3072000-choice1-main-header/1585186775716"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-zjk/zjk-industrial/news/november-2025s-top-penny-stocks-to-watch-1","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/capital-goods/nasdaq-zjk/zjk-industrial/news/november-2025s-top-penny-stocks-to-watch-1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BABB","PBYI","BK4509","BK4204","BK4134","BK4021","BK4526","LX","BK4180","ZJK","BK4173","LU1046422090.SGD","BK4579","BK4531","HERE","BK4505","BK4161","TUYA","BK4139","CINT","BK4539","FINV","BK4113","WDH","BK4551","LCUT","LU0049112450.USD","PSHG","NRDY","BK4209","BK4166","DDL","LU1235295612.USD","BK4023"],"gpt_icon":0},{"id":"2585103371","title":"Vanda Pharmaceuticals Leads 3 Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2585103371","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585103371?lang=en_us&edition=fundamental","pubTime":"2025-11-21 19:04","pubTimestamp":1763723098,"startTime":"0","endTime":"0","summary":"As the U.S. markets navigate a volatile landscape marked by significant swings in major stock indexes, investors are increasingly seeking opportunities beyond the usual tech giants. Penny stocks, often representing smaller or newer companies, continue to pique interest despite their somewhat outdated label. These stocks can offer surprising value and potential growth when backed by strong financial health, making them an intriguing option for those looking to explore diverse investment avenues.","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3242000-choice2-main-header/1585186741316"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/transportation/otc-tsph/createai-holdings/news/vanda-pharmaceuticals-leads-3-promising-penny-stocks","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/transportation/otc-tsph/createai-holdings/news/vanda-pharmaceuticals-leads-3-promising-penny-stocks","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1235295612.USD","PSHG","VNDA","BK4023","BK4232","LU0049112450.USD","BK4209","BK4173","BK4531","LU1046422090.SGD","API.AU","BK4509","BK4113","BK4134","HERE","LCUT","WDH","BK4166","BK4579","DDL","BK4539","API","BK4180","BK4204","BK4503","BABB","PBYI","BK4535","BK4551","LX","BK4139","TSPH","FINV","BK4021","BK7103","CINT"],"gpt_icon":0},{"id":"2584028929","title":"Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2584028929","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584028929?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:07","pubTimestamp":1763572057,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc ::*PUMA BIOTECHNOLOGY REPORTS INDUCEMENT AWARDS UNDER NASDAQ LISTING RULE 5635(C)(4)  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 07-NOV-202522:05:00.093 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD3hFMgK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2584296569","title":"Puma Biotechnology Q3 Adjusted EPS USD 0.21","url":"https://stock-news.laohu8.com/highlight/detail?id=2584296569","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584296569?lang=en_us&edition=fundamental","pubTime":"2025-11-20 00:58","pubTimestamp":1763571484,"startTime":"0","endTime":"0","summary":"Nov 06 (Reuters) - Puma Biotechnology Q3 product revenue USD 51.9 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 06-NOV-202521:05:48.747 GMT","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD99cmj4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0},{"id":"2584677769","title":"Puma Biotechnology Showcases Pipeline Progress and NERLYNX Commercial Updates in New Corporate Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2584677769","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584677769?lang=en_us&edition=fundamental","pubTime":"2025-11-18 06:33","pubTimestamp":1763418812,"startTime":"0","endTime":"0","summary":"Puma Biotechnology Inc. presented updates on the commercialization of NERLYNX, including recent performance metrics and distribution network information. The company reported net revenue of $51.9 million in Q3 2025, reflecting an approximately 8% decrease compared to Q3 2024, but a 6% increase from Q2 2025. Inventory changes amounted to $3.1 million in Q3 2025, up from $0.7 million in Q3 2024 and -$1.3 million in Q2 2025. The number of bottles distributed in Q3 2025 was 2,723, compared to 2,949 in Q3 2024 and 2,608 in Q2 2025. The percentage of patients starting NERLYNX at a reduced dose continued to fluctuate, with the latest figures indicating varying adoption rates. The company also provided a regional update on regulatory approvals and commercial launches, highlighting recent progress in Australia, Southeast Asia, and other markets. You can access the full presentation through the link below.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nNDL4H6Yz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBYI","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pumabiotechnology.com","stockEarnings":[{"period":"1week","weight":0.0015},{"period":"1month","weight":0.0897},{"period":"3month","weight":0.3906},{"period":"6month","weight":0.1867},{"period":"1year","weight":1.4373},{"period":"ytd","weight":0.1429}],"compareEarnings":[{"period":"1week","weight":0.0054},{"period":"1month","weight":-0.018},{"period":"3month","weight":0.0139},{"period":"6month","weight":0.0588},{"period":"1year","weight":0.1291},{"period":"ytd","weight":-0.001}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company offers NERLYNX, an oral version of neratinib that is used to treat adult patients with early stage HER2-overexpressed/amplified breast cancer; and advanced or metastatic HER2-positive breast cancer when combined with capecitabine. It also develops alisertib, a small molecule inhibitor of aurora kinase A for the treatment of hormone receptor positive breast cancer, triple negative breast cancer, small cell lung cancer, and head and neck cancer. The company sells its products through specialty pharmacy and distributor networks. It has license agreements with Pfizer Inc. for the development, manufacture, and commercialization of neratinib (oral), neratinib (intravenous), PB357, and related compounds; and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of alisertib, as well as sub-license agreements with Specialised Therapeutics Asia Pte Ltd., Medison Pharma Ltd., Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.008257},{"month":2,"riseRate":0.571429,"avgChangeRate":0.067513},{"month":3,"riseRate":0.461538,"avgChangeRate":-0.007631},{"month":4,"riseRate":0.384615,"avgChangeRate":-0.055539},{"month":5,"riseRate":0.692308,"avgChangeRate":0.050713},{"month":6,"riseRate":0.538462,"avgChangeRate":-0.014244},{"month":7,"riseRate":0.538462,"avgChangeRate":0.191575},{"month":8,"riseRate":0.538462,"avgChangeRate":0.046611},{"month":9,"riseRate":0.538462,"avgChangeRate":-0.010996},{"month":10,"riseRate":0.307692,"avgChangeRate":-0.121353},{"month":11,"riseRate":0.5,"avgChangeRate":0.134879},{"month":12,"riseRate":0.285714,"avgChangeRate":0.023235}],"exchange":"NASDAQ","name":"Puma Biotechnology","nameEN":"Puma Biotechnology"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Puma Biotechnology(PBYI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Puma Biotechnology,PBYI,Puma Biotechnology股票,Puma Biotechnology股票老虎,Puma Biotechnology股票老虎国际,Puma Biotechnology行情,Puma Biotechnology股票行情,Puma Biotechnology股价,Puma Biotechnology股市,Puma Biotechnology股票价格,Puma Biotechnology股票交易,Puma Biotechnology股票购买,Puma Biotechnology股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Puma Biotechnology(PBYI),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Puma Biotechnology(PBYI) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction